Drug discovery approaches to irritable bowel syndrome
@article{Hornby2015DrugDA, title={Drug discovery approaches to irritable bowel syndrome}, author={P. Hornby}, journal={Expert Opinion on Drug Discovery}, year={2015}, volume={10}, pages={809 - 824} }
Introduction: Irritable bowel syndrome (IBS) is defined by symptoms of abdominal pain and altered bowel habits without detectable organic disease. Antidepressants and serotonin receptor modulators are used to treat IBS, but rare serious adverse events highlight the safety hurdle. Newer drugs with secretory and motility effects via local gut mechanisms have been successfully approved for IBS, often by registering first in a related, non-IBS condition to optimize dosing, formulation and… Expand
Topics from this paper
9 Citations
How can we develop better antispasmodics for irritable bowel syndrome?
- Medicine
- Expert opinion on drug discovery
- 2019
- 1
Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome
- Medicine
- Clinical and translational gastroenterology
- 2019
- 1
- PDF
G protein‐coupled estrogen receptor and estrogen receptor ligands regulate colonic motility and visceral pain
- Biology, Medicine
- Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
- 2017
- 25
Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.
- Biology, Medicine
- Handbook of experimental pharmacology
- 2017
- 30
Enteric Neuronal Regulation of Intestinal Inflammation
- Biology, Medicine
- Trends in Neurosciences
- 2016
- 44
- PDF
Systemic administration of the bifunctional opioid/neuropeptide FF receptors agonist BN‐9 produced peripheral antinociception in preclinical mouse models of pain
- Medicine
- European journal of pharmacology
- 2018
- 2
MAHMI database: a comprehensive MetaHit-based resource for the study of the mechanism of action of the human microbiota
- Computer Science, Medicine
- Database J. Biol. Databases Curation
- 2017
- 29
- PDF
References
SHOWING 1-10 OF 151 REFERENCES
Emerging receptor target in the pharmacotherapy of irritable bowel syndrome with constipation
- Medicine
- Expert review of gastroenterology & hepatology
- 2013
- 17
- Highly Influential
Irritable bowel syndrome: the role of food in pathogenesis and management.
- Medicine
- Gastroenterology & hepatology
- 2014
- 30
- PDF
The safety of novel drugs used to treat irritable bowel syndrome
- Medicine
- Expert opinion on drug safety
- 2014
- 12
Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome
- Medicine
- Expert opinion on pharmacotherapy
- 2013
- 44
Irritable bowel syndrome neuropharmacology. A review of approved and investigational compounds.
- Medicine
- Journal of clinical gastroenterology
- 2002
- 58
- Highly Influential
Pharmacologic Therapy for the Irritable Bowel Syndrome
- Medicine
- American Journal of Gastroenterology
- 2003
- 61
Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome.
- Medicine
- Gut microbes
- 2014
- 29
Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.
- Medicine
- World journal of gastroenterology
- 2014
- 33
The quest for biomarkers in IBS—where should it lead us?
- Medicine
- Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
- 2014
- 24